Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1989-5-12
|
pubmed:abstractText |
Nedocromil sodium, a pyranoquinoline decarboxylic acid derivative, is a new antiasthma compound undergoing clinical investigation. It has been shown to be effective in the management of asthma and to attenuate exercise-induced bronchoconstriction. We performed a randomized, double-blind, placebo-controlled, crossover study in 12 ragweed-sensitive subjects known to respond to inhaled ragweed antigen. On two study days, four to ten days apart, ragweed challenges were performed using a standard protocol 30 minutes after a single dose (two puffs of 2 mg/puff) of either active drug or placebo. The PD20 (20% fall in FEV1) for each treatment day was compared by parametric and nonparametric 2-period crossover analyses. Baseline FEV1 pre-drug and post-drug administration did not differ significantly between study days. On the nedocromil day, the mean +/- SD for log PD20 was 2.25 +/- 0.561 and on the placebo day, 1.73 +/- 1.048 (P = 0.04). There were no side effects associated with either treatment. These results demonstrate that nedocromil is effective in shifting the stimulus response curve to inhaled antigen in some ragweed-sensitive subjects. Its wide spectrum of efficacy against bronchoprovocation suggests it is useful in the treatment of hyperreactive airway disorders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0003-4738
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
329-31
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2539764-Administration, Inhalation,
pubmed-meshheading:2539764-Adult,
pubmed-meshheading:2539764-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:2539764-Antigens,
pubmed-meshheading:2539764-Asthma,
pubmed-meshheading:2539764-Bronchi,
pubmed-meshheading:2539764-Bronchial Provocation Tests,
pubmed-meshheading:2539764-Constriction, Pathologic,
pubmed-meshheading:2539764-Forced Expiratory Volume,
pubmed-meshheading:2539764-Humans,
pubmed-meshheading:2539764-Male,
pubmed-meshheading:2539764-Middle Aged,
pubmed-meshheading:2539764-Nedocromil,
pubmed-meshheading:2539764-Quinolones,
pubmed-meshheading:2539764-Time Factors
|
pubmed:year |
1989
|
pubmed:articleTitle |
Effect of nedocromil on antigen-induced bronchoconstriction in asthmatic subjects.
|
pubmed:affiliation |
Allergic Disease Center, Creighton University, Omaha, Nebraska.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|